NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
MilitaryTrumpStrikesMajorFebruaryIranAnnouncesMarketTariffsAdditionalIranianNewsDigestSundayTimelineUkraineNuclearTargetingGamePrivateEnergyTradeYearsHumanoid
MilitaryTrumpStrikesMajorFebruaryIranAnnouncesMarketTariffsAdditionalIranianNewsDigestSundayTimelineUkraineNuclearTargetingGamePrivateEnergyTradeYearsHumanoid
All Articles
STAT News
Published 6 days ago

STAT+: Medicare Advantage growth dwindles for a second straight year

STAT News · Feb 16, 2026 · Collected from RSS

Summary

Amid major changes to Medicare Advantage, some big insurers have been working to shrink their rolls.

Full Article

Nearly every major Medicare insurer got rid of enrollees — except Humana Adobe By Bob HermanFeb. 16, 2026 Business of Health Care Reporter Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09. The Medicare Advantage program continues to bring in more older adults and people with disabilities, but not nearly at the same rates from just a few years ago. Almost 35.5 million people were enrolled in a Medicare Advantage plan as of Feb. 1, up roughly 3% from 34.4 million at the same time in 2025, according to new federal data analyzed by STAT. The growth during Medicare’s annual enrollment window, which runs from Oct. 15 through Dec. 7, stagnated — with enrollment increasing just 1%. By comparison, annual enrollment growth in Medicare Advantage ranged between 7% and 10% between 2017 and 2024, according to historical data analysis by STAT. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Business of Health Care Reporter Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.


Share this story

Read Original at STAT News

Related Articles

STAT News2 days ago
STAT+: Nature Medicine to investigate study that found cancer treatment is better in morning

Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the morning.

STAT News2 days ago
STAT+: DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition

Regulators say Ohio hospital system made it difficult for health insurers to offer cheaper plans.

STAT News2 days ago
STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

STAT News2 days ago
STAT+: Element Biosciences launches table-top sequencer capable of $100 genome

And other biotech news brought to you by The Readout newsletter

STAT News2 days ago
STAT+: Pharmalittle: We’re reading about an FDA official’s speech, a Grail cancer blood test, and much more

The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV

STAT News2 days ago
ACIP meeting postponed, for reasons that are unclear

And other health news from today's Morning Rounds newsletter